Articles

CAR T-cell immunotherapy is highly efficient because of its ability to target specific tumor antigens. Preliminary evidence suggests that CAR T-cells directed against CD117, the KIT receptor, may emerge as a therapeutic option for advanced systemic mastocytosis.
Read More

Cytogenetic aberrations are rarely found by cytogenetics in systemic mastocytosis but are associated with advanced disease. Whole genome sequencing detects both chromosomal aberrations and non-KIT gene mutations and can be used as an alternative to cytogenetics for assessing disease risk.
Read More

Navigation Is About Value
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+), said she attended the AVBCC Summit because oncology nurse and patient navigation is "all about value" across the cancer care continuum.
Read More

Navigators Need a Place at the Table
We are making progress, but oncology nurse navigators need to have a louder voice in these meetings with stakeholders because, as patient advocates, they are often the keepers of patient experience, said Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+).
Read More

Bringing the Patient Voice to Stakeholders
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+), said navigators have "boots on the ground" experiences with patients with cancer, their families, and their caregivers, and oncology navigators are the professionals best suited to deliver these voices to the stakeholders who need to hear them.
Read More

A Navigator for Every Patient
Every patient with cancer should have a navigator, said Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+), and she would like to see AVBCC take a role in realizing this vision.
Read More

Navigators Have Lessons to Share
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+), would like to see everyone with an interest in patient care come to the next AVBCC Summit and learn from navigators how to sustain navigation programs and to learn more about financial navigation.
Read More

Navigators Gather as Unified Presence
Oncology navigators should attend because the AVBCC Summit provides an opporutnity to come together as one unified voice and also to hear from others in the field, said Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+).
Read More

AVBCC Summit Best Conference to Address Questions About Value-Based Care
Sibel Blau, MD, President & CEO, Quality Cancer Care Alliance Network, Medical Director, Oncology Division, Northwest Medical Specialties, said her organization is interested in practice transformation and value-based care and AVBCC is the "best conference ever" to meet the individuals who can address questions about value-based care.
Read More

 Priceless Networking at AVBCC Summit
Understanding how other institutions, practices, and companies are envisioning the future of value-based care is an invaluable benefit, and the chance to network with others is "priceless," said Sibel Blau, MD, President & CEO, Quality Cancer Care Alliance Network, Medical Director, Oncology Division, Northwest Medical Specialties.
Read More

Page 31 of 329